Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Fidarestat is an aldose reductase inhibitor (IC50s: 26 nM, 33 μM, and 1.8 μM for aldose reductase, AKR1B10, and V301L AKR1B10, respectively). It has the potential to treat diabetic disease.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | 4-5 weeks | $ 198.00 | |
5 mg | 4-5 weeks | $ 890.00 | |
10 mg | 4-5 weeks | $ 1,580.00 |
Description | Fidarestat is an aldose reductase inhibitor (IC50s: 26 nM, 33 μM, and 1.8 μM for aldose reductase, AKR1B10, and V301L AKR1B10, respectively). It has the potential to treat diabetic disease. |
Targets&IC50 | Aldose reductase:26 nM, AKR1B10:33 μM, AKR1B10 (V301L):1.8 μM |
In vivo | Fidarestat (1 or 4 mg/kg. p.o., daily for 4 weeks) decreases the concentrations of sorbitol and fructose in diabetic rats [2]. |
Synonyms | SNK 860 |
Molecular Weight | 279.22 |
Formula | C12H10FN3O4 |
CAS No. | 136087-85-9 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 250 mg/mL (895.35 mM), Sonification is recommended.
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Fidarestat 136087-85-9 Endocrinology/Hormones Metabolism Reductase SNK 860 SNK-860 SNK860 inhibitor inhibit